Targeting Antipeptide Antibodies Towards Cytochrome P450 Enzymes

  • Robert J. Edwards
Part of the Methods in Molecular Biology™ book series (MIMB, volume 107)


Antibodies against cytochrome P450 enzymes can be produced by immunizing animals with synthetic peptides that mimic small regions of the apoprotein. As the amino-acid sequences of a large number of cytochrome P450 enzymes are known (1), this approach to raising antibodies can be applied to most of the major cytochrome P450 enzymes in human, rat and other species. This is a relattvely simple, rapid and effective method of producmg antibodies.


Cysteine Thiol Diethyl Glutaraldehyde Lysozyme 


  1. 1.
    Nelson, D. R., Koymans, L, Kamataki, T, Stegeman, J. J., Feyeretsen, R, Waxman, D. J., Waterman, M. R, Gotoh, O., Coon, M. J., Estabrook, R. W, Gunsalus, I. C., and Nebert, D. W (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetzcs 6, 1–42CrossRefGoogle Scholar
  2. 2.
    Parkinson, A. and Gemzlk, B. (1991) Production and purtticatron of anttbodies against rat liver P450 enzymes. Methods Enzymol. 56, 233–245.CrossRefGoogle Scholar
  3. 3.
    Thomas, P. E., Bandiera, S., Reik, L. M., Mames, S. L, Ryan, D. E., and Levm, W. (1987) Polyclonal and monoclonal antibodies as probes of rat hepatic cytochrome P-450 isozymes. Fed Proc. 46, 2563–2566PubMedGoogle Scholar
  4. 4.
    Wrighton, S. A., Vandenbranden, M., Becker, G, W., Black, S D., and Thomas, P. E. (1992) Two monoclonal antrbodres recognizing different epitopes on rat cytochrome IIB 1 react with human IIE 1. Mol Pharmacol 41, 76–82.PubMedGoogle Scholar
  5. 5.
    Goldfarb, I., Korzekwa, K., Krausz, K. W, Gonzalez, F., and Gelbom, H V. (1993) Cross-reactivity of thirteen monoclonal anttbodies with ten vaccima cDNA expressed rat, mouse and human cytochrome P45Os Biochem Pharmacol 46, 787–790.PubMedCrossRefGoogle Scholar
  6. 6.
    Edwards, R. J., Murray, B. P., Singleton, A. M., Murray, S., Davies, D S., and Boobis, A R. (1993) Identification of the epttope of an anti-peptide antibody which binds to CYPlA2 in many species including man Biochem Pharmacol 46, 213–220PubMedCrossRefGoogle Scholar
  7. 7.
    Edwards, R. J., Smgleton, A. M, Murray, B P., Davies, D. S, and Boobts, A. R (1995) Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termmi of cytochrome P450 enzymes. Biochem Pharmacol. 49, 39–47.PubMedCrossRefGoogle Scholar
  8. 8.
    Anilkumar, T. V., Goidmg, M., Edwards, R. J., Lalani, E., Sarraf, C. E, and Alison, M, R. (1995) The resistant hepatocyte model of carcmogenesrs in the rat the apparent Independent development of oval cell proliferation and early nodules. Carcinogenesis 16, 845–853.PubMedCrossRefGoogle Scholar
  9. 9.
    Goldmg, M., Sarraf, C. E., Lalam, E., Anilkumar, T V., Edwards, R J, Nagy, P, Thorgeirsson, S. S., and Ahson, M R. (1995) Oval cell differentiation mto hepatocytes in the acetylaminofluorene-treated regenerating rat liver. Hepatologv 22, 1243–1253.Google Scholar
  10. 10.
    Edwards, R. J, Singleton, A. M., Murray, B. P., Murray, S., Boobts, A R, and Davies, D. S. (1991) Identification of a functionally conserved surface region of rat cytochromes P450IA. Biochem. J 278, 749–757PubMedGoogle Scholar
  11. 11.
    Edwards, R. J., Singleton, A M., Murray, B. P., Sesardic, D., Rich, K J, Davies, D. S., and Boobis, A. R(1990) An anti-peptide antibody targeted to a specrtic region of rat cytochrome P450IA2 inhibits enzyme activity. Biochem J. 266, 497–504.PubMedGoogle Scholar
  12. 12.
    Adams, D. A., Edwards, R. J., Davies, D S., and Boobis, A R. (1997) Specific inhibition of human CYPlA2 using a targeted antibody. Biochem. Pharm 54, 189–197PubMedCrossRefGoogle Scholar
  13. 13.
    Rich, K J, Sesardic, D, Foster, J R, Davies, D. S., and Boobis, A. R. (1989) Immunohlstochemical localization of cytochrome P450b/e in hepatlc and extrahepatic tissues of the rat. Biochem Pharmacol. 38, 3305–3322.PubMedCrossRefGoogle Scholar
  14. 14.
    Debra, K., Boobis, A. R., Davies, D. S, and Edwards, R J (1995) Dlstributton and mduction of CYP3Al and CYP3A2 in rat liver and extra-hepattc tissues Biochem Pharmacot 50, 2047–2056.CrossRefGoogle Scholar
  15. 15.
    Edwards, R. J., Murray, B. P., and Boobis, A R. (1991) Anti-pepttde antibodies in studies of cytochromes P450IA. Methods Enzymol 206, 220–233PubMedCrossRefGoogle Scholar
  16. 16.
    Edwards, R. J., Murray, B. P., Boobis, A. R., and Davies, D. S (1989) Identification and location of alpha-hehces in mammalian cytochromes P450. Biochemzstry 28, 3762–3770CrossRefGoogle Scholar
  17. 17.
    Edwards, R. J, Murray, B. P., Singleton, A. M., and Boobis, A. R (1991) Orientation of cytochromes P450 in the endoplasmic reticulum. Biochemwtry 30, 7 l–76.Google Scholar
  18. 18.
    Pearson, W. R. and Miller, W. (1992) Dynamic programming algorithms for biological sequence comparison Methods Enzymol. 210, 575–601.PubMedCrossRefGoogle Scholar
  19. 19.
    Pennmgton, M W and Dunn, B. M. (1994) Peptide Syntheses Protocols Humana, Totowa.CrossRefGoogle Scholar
  20. 20.
    Atherton, E. and Sheppard, R C. (1989) Solid phase peptide synthesis—a practical approach. IRL Press, Oxford University, Oxford, UK.Google Scholar
  21. 21.
    Edwards, R. J., Singleton, A. M., Sesardic, D., Boobis, A R., and Davies, D. S (1988) Antibodies to a synthetic peptide that react specrfically with a common surface region on to hydrocarbon-inducible isoenzymes of cytochrome P-450 Biochem. Pharmacol 37, 3735–3741.PubMedCrossRefGoogle Scholar
  22. 22.
    Edwards, R. J., Murray, B. P, Murray, S, Schulz, T., Neubert, D., Gant, T W, Thorgeirsson, S. S., Boobis, A. R., and Davies, D S (1994) Contribution of CYPl Al and CYPlA2 to the activation of heterocychc ammes in monkeys and human. Carclnogenesis 15, 829–836.CrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 1998

Authors and Affiliations

  • Robert J. Edwards
    • 1
  1. 1.Section on Clinical PharmacologyImperial College School of MedicineLondonUK

Personalised recommendations